Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial

Clinical Trial ID NCT00110448

Rank	Title	Journal	Year	PubWeight™‹?›
1	Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.	JAMA	2008	6.15
2	Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions.	Diabetes Care	2009	1.03
3	Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study.	PLoS One	2016	0.78
4	Low-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis from the JPAD trial.	Diabetes Care	2011	0.77
5	Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetes management: a subanalysis of the JPAD trial.	Diabetes Care	2011	0.75
6	Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes: 10-year Follow-up of a Randomized Controlled Trial.	Circulation	2016	0.75
7	Antiplatelet agents for chronic kidney disease.	Cochrane Database Syst Rev	2022	0.75